OPTIMA: improving prostate cancer treatment through AI

The European Association of Urology (EAU) is co-coordinating OPTIMA: a public-private partnership of 36 partners spanning 13 countries that officially launched earlier this week.

Thu, 14 Oct 2021
OncologyProstate CancerOPTIMA

OPTIMA's aim is to revolutionise oncology care in Europe by improving broad data access, using AI-driven technology and tools, and strengthening shared decision-making based on dynamic computer-interpretable guidelines. This all originates from OPTIMA's vision, which says that every patient should have access to the most up-to-date individualised treatments and innovative therapies. OPTIMA focusses specifically on breast, lung, and prostate cancer. It is funded by the Innovative Medicines Initiative (IMI).

Please watch the video below for a full introduction of OPTIMA. For more information, please visit the project website at www.optima-oncology.eu or follow OPTIMA on Twitter @OPTIMA_oncology.